Ubs Group Ag Clovis Oncology, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.05 - $2.85 $59 - $162
-57 Reduced 1.33%
4,239 $5,000
Q2 2022

Aug 10, 2022
SELL
$0.63 - $2.96 $43 - $204
-69 Reduced 1.58%
4,296 $8,000
Q1 2022

May 16, 2022
SELL
$1.43 - $3.14 $1.56 Million - $3.43 Million
-1,092,099 Reduced 99.6%
4,365 $9,000
Q4 2021

Feb 14, 2022
BUY
$2.7 - $4.76 $402,194 - $709,054
148,961 Added 15.72%
1,096,464 $2.97 Million
Q3 2021

Nov 15, 2021
BUY
$4.06 - $5.8 $2.63 Million - $3.76 Million
648,662 Added 217.06%
947,503 $4.23 Million
Q2 2021

Aug 13, 2021
SELL
$5.02 - $7.05 $1.26 Million - $1.77 Million
-251,564 Reduced 45.71%
298,841 $1.73 Million
Q1 2021

May 12, 2021
BUY
$4.81 - $10.34 $1.38 Million - $2.96 Million
286,372 Added 108.46%
550,405 $3.86 Million
Q4 2020

Feb 11, 2021
BUY
$4.13 - $6.41 $37,314 - $57,914
9,035 Added 3.54%
264,033 $1.27 Million
Q3 2020

Nov 12, 2020
BUY
$4.82 - $7.72 $211,588 - $338,892
43,898 Added 20.79%
254,998 $1.49 Million
Q2 2020

Jul 31, 2020
BUY
$5.69 - $9.69 $329,883 - $561,787
57,976 Added 37.86%
211,100 $1.43 Million
Q1 2020

May 01, 2020
BUY
$3.77 - $11.0 $434,918 - $1.27 Million
115,363 Added 305.51%
153,124 $974,000
Q4 2019

Feb 14, 2020
SELL
$3.0 - $16.43 $2.67 Million - $14.6 Million
-889,214 Reduced 95.93%
37,761 $394,000
Q3 2019

Nov 14, 2019
BUY
$3.93 - $15.35 $830,004 - $3.24 Million
211,197 Added 29.51%
926,975 $3.64 Million
Q2 2019

Aug 14, 2019
BUY
$12.81 - $25.67 $8.84 Million - $17.7 Million
690,441 Added 2725.03%
715,778 $10.6 Million
Q1 2019

May 14, 2019
SELL
$17.66 - $30.28 $5.65 Million - $9.68 Million
-319,704 Reduced 92.66%
25,337 $629,000
Q4 2018

Feb 14, 2019
BUY
$11.63 - $32.67 $3.64 Million - $10.2 Million
313,376 Added 989.66%
345,041 $6.2 Million
Q3 2018

Nov 14, 2018
SELL
$29.37 - $49.48 $534,064 - $899,744
-18,184 Reduced 36.48%
31,665 $930,000
Q2 2018

Aug 14, 2018
SELL
$42.06 - $62.4 $3.06 Million - $4.53 Million
-72,649 Reduced 59.31%
49,849 $2.27 Million
Q1 2018

May 15, 2018
BUY
$50.12 - $67.72 $2.62 Million - $3.54 Million
52,206 Added 74.27%
122,498 $6.47 Million
Q4 2017

Feb 14, 2018
SELL
$57.69 - $84.58 $552,900 - $810,614
-9,584 Reduced 12.0%
70,292 $4.78 Million
Q3 2017

Nov 14, 2017
BUY
$67.17 - $84.81 $2.89 Million - $3.65 Million
42,987 Added 116.53%
79,876 $6.58 Million
Q2 2017

Aug 14, 2017
BUY
N/A
30,568 Added 483.59%
36,889 $3.45 Million
Q1 2017

Nov 14, 2017
BUY
N/A
6,321
6,321 $402,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email